[stock-market-ticker symbols="AAPL;MSFT;GOOG;HPQ;^SPX;^DJI;LSE:BAG" stockExchange="NYSENasdaq" width"100%" palette="financial-light"]

Pfizer Quietly Adds Language Warning That 'Unfavorable Pre-Clinical, Clinical Or Safety Data' May Impact Business

By CDM Staff

February 8, 2022

No Comments

Anthony Fauci’s Trench Warfare Approach To Covid-19

Please Follow us on Gab, Minds, Telegram, Rumble, Gab TV, GETTR

Two weeks ago, the FDA begged a Texas judge to delay production on the first monthly batch of 55,000 pages of Covid-19 vaccine data submitted to the agency by Pfizer. Originally, the agency was set to produce just 500 pages-per-month.

Now, Pfizer - which just forecast $54 billion in Covid-related sales in 2022, appears to be anticipating some bad news, as evidenced by several redline changes in their Q4 earnings releases.

As Rubicon Capital's Kelly Brown notes on Twitter, the changes center around disclosures of unfavorable safety data.

For example, in Q4 they added: "or further information regarding the quality of pre-clinical, clinical or safety data, including by audit or inspection."

To read more visit Zero Hedge.

We simply need your help to continue bringing the truth...shameless plug for desperately needed donations at this link...

SHARE THIS ARTICLE

Author

CDM Staff

The mission at Creative Destruction Media is to be the catalyst for the "process of industrial mutation that incessantly revolutionizes the economic structure from within, incessantly destroying the old one, incessantly creating a new one."